RecruitingNCT07029529
Apremilast for adults with alcohol use disorder
About this title
Read the official source — NCT07029529Medication studyAges 21–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
What will I do during this study?
After an intake session and physical examination, you are assigned to apremilast or placebo (an inactive comparison treatment) tablets taken twice daily. You also complete three laboratory sessions involving guided imagery followed by a period when you can choose to drink alcohol. Further assessments continue for one month after the study medication is stopped.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 12, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 80
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT07029529
- Official title
Show the full official title
Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Apremilast 60mg.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
